Jason Simon has extensive experience in precision medicine and translational research, with a career spanning over two decades in the pharmaceutical and biotech industries. Currently serving at Regeneron since May 2022 in Precision Medicine, Jason's previous roles include positions at Black Diamond Therapeutics, Johnson & Johnson, and several divisions of Janssen Pharmaceuticals, where responsibilities encompassed leading development activities for companion diagnostics, and managing clinical development in oncology and immuno-oncology. Earlier roles involved directing programs at Bristol-Myers Squibb and Eisai, focusing on biomarkers and pharmacogenetics. Jason's foundational work at Schering-Plough and Genome Therapeutics involved advancing genetic research to support clinical trials, alongside a fellowship at Massachusetts General Hospital. Jason holds a Ph.D. in Pharmacology from the University of Iowa and a bachelor's degree from Emory University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices